Is laparotomy better than laparoscopic surgery in early cervical cancer?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jeong In | - |
dc.contributor.author | Sang, Jae Hong | - |
dc.contributor.author | Chung, Soo-Ho | - |
dc.date.accessioned | 2021-08-11T08:31:19Z | - |
dc.date.available | 2021-08-11T08:31:19Z | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 0392-2936 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2234 | - |
dc.description.abstract | Introduction: Cervical cancer is the fourth most common cancer among women worldwide. Conventional open cervical cancer surgery was often performed in the past, but laparoscopic/robot-assisted surgery is now more common, in accordance with the recent trend toward increased use of minimally invasive surgery. Materials and methods: A total of 266 patients with early cervical cancer, who underwent type II, III radical hysterectomy with or without pelvic lymphadenectomy during the 10-year period between March 2008 and February 2018 at a tertiary hospital (performed by three surgeons), were divided into laparotomy (group 1, n = 132) and laparoscopic/robot-assisted surgery (group 2, n = 134) groups. The variables of interest in this retrospective chart review study were age, body mass index (BMI), cancer stage, surgery type (laparotomy or laparoscopic/robot-assisted), pathology, complications after surgery, additional therapy after surgery, recurrence, and mortality. Results: The surgery type differed significantly according to cancer stage: patients in early and later stages were more likely to undergo laparotomy and laparoscopic/robot-assisted surgery, respectively (p = 0.016). Patients with a higher BMI were more likely to undergo laparoscopic/robot-assisted surgery (p = 0.032). Most patients (n = 170) received adjuvant therapy following surgery. The cervical cancer recurrence rate was 8.3% (11/132) group 1 and 8.2% (11/134) group 2 (p = 0.573). The proportion of postsurgical complications was similar, 8% in group 1 and 5% in group 2, p = 0.469. Conclusions: In this heterogeneous group of patients, most of whom received adjuvant therapy, with found no difference by univariate analysis in the mortality or recurrence rate or the rate of postoperative complications. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | S O G Canada Inc. | - |
dc.title | Is laparotomy better than laparoscopic surgery in early cervical cancer? | - |
dc.type | Article | - |
dc.publisher.location | 캐나다 | - |
dc.identifier.doi | 10.31083/j.ejgo.2020.06.2180 | - |
dc.identifier.scopusid | 2-s2.0-85098885939 | - |
dc.identifier.wosid | 000598901600018 | - |
dc.identifier.bibliographicCitation | European Journal of Gynaecological Oncology, v.41, no.6, pp 949 - 951 | - |
dc.citation.title | European Journal of Gynaecological Oncology | - |
dc.citation.volume | 41 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 949 | - |
dc.citation.endPage | 951 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.subject.keywordPlus | MINIMALLY INVASIVE SURGERY | - |
dc.subject.keywordPlus | RADICAL HYSTERECTOMY | - |
dc.subject.keywordAuthor | Uterine cervical neoplasms | - |
dc.subject.keywordAuthor | Laparotomy | - |
dc.subject.keywordAuthor | Laparoscopy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.